Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer.
Wen LiChen GanSheng YuJian XuLingXue TangHuaidong ChengPublished in: Molecular neurobiology (2024)
Wnt3a/GSK3 β/β-catenin signalling is likely involved in doxorubicin-induced memory impairment. This result provides basic evidence for the further study of chemobrain in breast cancer.